Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356633 (1-(3-(9H-carbazol-9-yl)-2-hydroxypropyl)piperidin-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 171 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356634 (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl)-3- fluo...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 61 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356635 (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl)-3- meth...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 736 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356636 (US10214507, Compound 71 | US10759777, Compound 71) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 188 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356638 (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl) tetrahy...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 299 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356639 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase PC cid PC sid PDB UniChem | US Patent | n/a | n/a | n/a | n/a | 389 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356640 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 192 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356641 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.11E+3 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356642 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 536 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356643 (1-cyclohexyl-3-(3- (3,6-difluoro-9H- carbazol-9-yl...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 284 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356644 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 719 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356645 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 171 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356646 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 625 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356648 (1-cyclopentyl-3-(3- (3,6-difluoro-9H- carbazol-9-y...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 609 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356649 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 527 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356650 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 620 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356653 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 300 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356654 (1-cyclobutyl-3-(3- (3,6-difluoro-9H- carbazol-9-yl...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 440 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356655 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 487 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356656 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 923 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356658 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 120 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356659 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.11E+3 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356660 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 909 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356661 (1-cyclobutyl-3-(3- (3,6-difluoro-9H- carbazol-9-yl...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 816 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356663 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 288 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356664 (1-cyclohexyl-3-(3- (3,6-difluoro-9H- carbazol-9-yl...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.19E+3 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356665 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 541 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356666 (1-cyclopropyl-3-(3- (3,6-difluoro-9H- carbazol-9-y...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 147 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356668 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 164 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356669 (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl)imid- az...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 325 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356670 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 463 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356671 (US10214507, Compound 85 | US10759777, Compound 85) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 667 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356672 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 417 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356674 (US10214507, Compound 86 | US10759777, Compound 86) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 497 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356675 (3-cyclopentyl-1-(3- (3,6-difluoro-9H- carbazol-9-y...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 338 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356676 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 317 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356679 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 547 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356680 (1-cyclohexyl-3-(3- (3,6-difluoro-9H- carbazol-9-yl...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 310 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356683 (3-cyclohexyl-1-(3- (3,6-difluoro-9H- carbazol-9-yl...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 379 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356684 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 438 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356685 (3-cyclohexyl-1-(3- (3,6-difluoro-9H- carbazol-9-yl...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.04E+3 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356686 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 605 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356687 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 261 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356688 (1-cyclopentyl-3-(3- (3,6-difluoro-9H- carbazol-9-y...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 621 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356691 (3-cyclopentyl-1-(3- (3,6-difluoro-9H- carbazol-9-y...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 399 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356693 (1-cyclopropyl-3-(3- (3,6-difluoro-9H- carbazol-9-y...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 527 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356694 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 332 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356695 (1-cyclobutyl-3-(3- (3,6-difluoro-9H- carbazol-9-yl...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 129 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356696 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 79 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356697 (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 833 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) BindingDB Entry DOI: 10.7270/Q2KH0QMT | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 138 total ) | Next | Last >> |